Avanos Medical (NYSE:AVNS – Get Free Report) is projected to announce its earnings results before the market opens on Tuesday, February 18th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $177.23 million for the quarter.
Avanos Medical Trading Up 0.8 %
Avanos Medical stock opened at $16.64 on Tuesday. Avanos Medical has a 52-week low of $14.98 and a 52-week high of $25.36. The firm has a market capitalization of $764.68 million, a price-to-earnings ratio of 48.94 and a beta of 0.98. The firm has a 50-day moving average price of $16.74 and a two-hundred day moving average price of $20.33. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12.
Analysts Set New Price Targets
Separately, StockNews.com lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
- Five stocks we like better than Avanos Medical
- What is Short Interest? How to Use It
- Merck: 4 No-Brainer Reasons to Buy This Dip
- What is Forex and How Does it Work?
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Compound Interest and Why It Matters When Investing
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.
